pathology
revealed
News & Articles
Reveal Biosciences Announces the Launch of imageDx™ A Unique Cloud-based AI Pathology Platform
imageDx™ platform creates a new generation of Pathology Intelligence™ (SAN DIEGO, CA. Jan. 12, 2021) — Reveal Biosciences, Inc., an established AI data provider, has developed a powerful and dynamic SaaS pathology platform called imageDx™.
AI Powered Pathology and Spatial Genomics: a Precision Medicine Approach
Spatial genomics and digital pathology continue to evolve at a rapid pace, generating large amounts of data. There is a critical unmet need for advanced tools to expedite spatial data generation, visualization, and analysis to
Data Powered Histopathology for IBD Research
Millions of people worldwide suffer from inflammatory bowel disease (IBD). In 2015, 3 million adults in the U.S. were diagnosed with IBD, with 70,000 new cases reported. IBD consists of two major disorders: ulcerative colitis
Poster – Quantitative Histopathological Analysis of a Diet-Induced NASH Mouse Model Using Artificial Intelligence
In a unique collaboration between multiple companies, Reveal has applied deep learning-based models to validate a diet-induced mouse NASH model that can be utilized in directed research studies for therapeutic drug development. Along with the
Validation of a NASH Mouse Model – White Paper
Validation of an Off-the-Shelf, Diet-Induced NASH Mouse Model using Digital Whole Slide Scanning of Liver Tissue and Artificial Intelligence-Enabled, Quantitative Histopathological Analysis Download the PDF White Paper Summary: Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
COVID-19: New Histopathology Capabilities for Research
Collaboration within the scientific community is essential for rapid progress. Our highly skilled team is ready to accelerate your COVID-19 research. In this time of uncertainty one thing is clear – accurate data matters. Quantitative In
NASH: IHC Digital Assays for Immune Cell Quantification
Research into developing effective treatments for non-alcoholic steatohepatitis (NASH) is becoming more important as the incidence of NASH increases in the general population. Mouse and rat models are used in the development of NASH therapeutics
Deep Learning-Based Assessment and Sophisticated Quantification for Wound Healing and Skin Metrics
The staggering cost of healthcare in America continues to rise, especially for wound healing. In 2014, wound-related healthcare expenses for Medicare beneficiaries were conservatively estimated at $28.1 billion, with over 8 million patients reporting at
Reveal Biosciences and QuantumCyte Partner to Offer a New Generation of Multi-omic Data
Precision medicine has come a long way towards benefiting patient outcomes and enhancing research tools. In recent years, the integration of multi-scale omics from genomic, proteomic, and transcriptomic foundations has impacted how biological pathways and
AI: Advancing Patient Access and Outcomes
Biocom’s 4th Annual Big Data Summit, held October 29, 2019 in La Jolla, CA, brought together thought leaders in artificial intelligence (AI), computational drug discovery, and blockchain technology. Throughout the day a recurring theme emerged:
